Open main menu
Home
Random
Recent changes
Special pages
Community portal
Preferences
About Wikipedia
Disclaimers
Incubator escapee wiki
Search
User menu
Talk
Dark mode
Contributions
Create account
Log in
Editing
Refractive error
(section)
Warning:
You are not logged in. Your IP address will be publicly visible if you make any edits. If you
log in
or
create an account
, your edits will be attributed to your username, along with other benefits.
Anti-spam check. Do
not
fill this in!
=== Medical treatment === Atropine has believed to slow the progression of near-sightedness and is administered in combination with multifocal lenses. These, however, need further research.<ref>{{Cite journal|last1=Shih|first1=Yung-Feng|last2=Hsiao|first2=C. Kate|last3=Chen|first3=Chien-Jen|last4=Chang|first4=Ching-Wei|last5=Hung|first5=Por T.|last6=Lin|first6=Luke L.-K.|date=June 2001|title=An intervention trial on efficacy of atropine and multi-focal glasses in controlling myopic progression|journal=Acta Ophthalmologica Scandinavica|volume=79|issue=3|pages=233β236|doi=10.1034/j.1600-0420.2001.790304.x|pmid=11401629|issn=1395-3907|doi-access=free}}</ref><ref>{{Cite journal|last1=Lee|first1=Jong-Jer|last2=Fang|first2=Po-Chiung|last3=Yang|first3=I-Hui|last4=Chen|first4=Chih-Hsin|last5=Lin|first5=Pei-Wen|last6=Lin|first6=Sue-Ann|last7=Kuo|first7=Hsi-Kung|last8=Wu|first8=Pei-Chang|date=February 2006|title=Prevention of Myopia Progression with 0.05% Atropine Solution|url=http://dx.doi.org/10.1089/jop.2006.22.41|journal=Journal of Ocular Pharmacology and Therapeutics|volume=22|issue=1|pages=41β46|doi=10.1089/jop.2006.22.41|pmid=16503774|issn=1080-7683|url-access=subscription}}</ref>
Edit summary
(Briefly describe your changes)
By publishing changes, you agree to the
Terms of Use
, and you irrevocably agree to release your contribution under the
CC BY-SA 4.0 License
and the
GFDL
. You agree that a hyperlink or URL is sufficient attribution under the Creative Commons license.
Cancel
Editing help
(opens in new window)